Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 9, 2026 by

NEEDHAM, Mass., July 08, 2026 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage …

Source: Read full article on google.com